Private company
ACURA PHARMACEUTICALS, INC
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021
Where the money goes
Where each dollar of revenue went, fiscal 2021
- Research and development51¢$1.5M
- Selling, general and admin42¢$1.3M
- Interest7¢$200.0K
Out of $1.6M in revenue.3 The company lost money this year.
Financial statements
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $8.6M4 | $4.5M5 | $3.0M6 | $410.0K7 | $2.7M8 | $3.6M3 | $1.6M3 |
| Cost of revenue | |||||||
| Research and development | $2.6M4 | $4.0M5 | $3.7M6 | $1.8M7 | $1.5M8 | $1.8M3 | $1.5M3 |
| Selling, general and admin | $9.0M4 | $6.5M5 | $4.3M6 | $2.6M7 | $1.9M8 | $2.5M3 | $1.3M3 |
| Operating income | -$4.0M4 | -$6.6M5 | -$5.2M6 | -$3.9M7 | -$725.0K8 | -$758.0K3 | -$1.2M3 |
| Interest | $1.2M4 | $893.0K5 | $592.0K6 | $223.0K7 | $449.0K8 | $450.0K3 | $200.0K3 |
| Income tax | $04 | $05 | $26.6M7 | $07 | $08 | $03 | $03 |
| Net income | -$5.0M4 | -$7.4M5 | -$5.7M6 | -$3.8M7 | -$3.8M8 | -$1.2M3 | -$879.0K3 |
| Earnings per share | -$0.464 | -$0.625 | -$0.366 | -$0.187 | -$0.148 | -$0.043 | -$0.023 |
| Earnings per share (diluted) | -$0.464 | -$0.625 | -$0.366 | -$0.187 | -$0.148 | -$0.043 | -$0.023 |
No quarterly figures reported.
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $2.5M5 | $2.7M5 | $2.2M6 | $91.0K6 | $862.0K3 | $413.0K3 | $65.0K3 |
| Current assets | $14.1M4 | $5.9M5 | $2.6M6 | $461.0K7 | $1.2M8 | $1.2M3 | $372.0K3 |
| Total assets | $17.0M4 | $8.2M5 | $4.6M6 | $2.2M7 | $2.6M8 | $1.7M3 | $860.0K3 |
| Current liabilities | $3.2M4 | $3.5M5 | $4.6M6 | $1.4M7 | $1.1M8 | $7.5M3 | $515.0K3 |
| Long-term debt | $5.4M4 | $3.0M5 | $05 | $4.2M7 | $6.0M8 | ||
| Total liabilities | $9.1M4 | $7.0M5 | $4.6M6 | $5.8M7 | $7.3M8 | $7.6M3 | $682.0K3 |
| Shareholders’ equity | $7.9M5 | $1.2M6 | -$27.0K7 | -$3.6M8 | -$4.7M3 | -$5.9M3 | $178.0K3 |
| Shares outstanding | 11.8M shares4 | 11.8M shares5 | 20.8K shares6 | 21.0K shares7 | 21.3M shares8 | 21.6M shares3 | 65.1M shares3 |
Former names
- HALSEY DRUG CO INC/NEWOct 24, 1995 to Aug 16, 20042
Recent filings
- Oct 6, 20268-K
- Aug 20, 20268-K
- Jul 24, 20268-K
- Jun 29, 20268-K
- May 7, 20268-K
- Mar 10, 20268-K
- Jan 20, 20268-K
- Jan 15, 20264 OWNERSHIP DOCUMENT
- Jan 15, 20264 OWNERSHIP DOCUMENT
- Jan 15, 20264 OWNERSHIP DOCUMENT
- Dec 29, 20258-K
- Oct 24, 20258-K
- Sep 4, 20258-K
- Jul 21, 20258-K
- Jun 24, 20258-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8